Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma

Houot, R., Poeschel, V., Altmann, B., Angel, S., Thurner, L., Illmer, T., Andre, M., Dreyling, M., Maisonneuve, H., Tilly, H., Mayer, S., Casasnovas, O., Le Gouill, S., Offner, F., Cartron, G., Kerkhoff, A., Weber, T., Hoffmann, J., Ziepert, M., … Held, G. (2022). Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma. HemaSphere, 6(2), e672. https://doi.org/10.1097/hs9.0000000000000672
Authors:
Roch Houot
Viola Poeschel
Bettina Altmann
Stephanie Angel
Lorenz Thurner
Thomas Illmer
Marc Andre
Martin Dreyling
Hervé Maisonneuve
Hervé Tilly
Stephanie Mayer
Olivier Casasnovas
Steven Le Gouill
Fritz Offner
Guillaume Cartron
Andrea Kerkhoff
Thomas Weber
Joerg Hoffmann
Marita Ziepert
Wolfram Klapper
Emmanuel Itti
Dirk Hellwig
Giorgi Natchkebia
Laurence de Leval
Andreas Rosenwald
Corinne Haioun
Laurent Dercle
Philippe Gaulard
Gerhard Held
Affiliated Authors:
Laurent Dercle
Columbia Affiliation:
Subjects:
Lymphoid Neoplasms (OpenAlex Topic)
Chimeric Antigen Receptor T Cell Therapy (OpenAlex Topic)
Natural Killer Cells in Immunity (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1097/hs9.0000000000000672
PMID:
35028526
DOI:
10.1097/hs9.0000000000000672
Journal:
HemaSphere
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View OpenAlex Record

Record Created: